Suero, Mark Kloe C.
HRN: 22-28-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/24/2025
CEFUROXIME 750MG (VIAL)
06/24/2025
07/01/2025
IV
400 Mg
Q 8 Hours
UTI; URTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes